Investor Relations
Latest Financial Results
May 1, 2024 • 4:15 PM EDT
Q1 2024 Quarterly Results
Quarter Ended Mar 31, 2024
$63M
Executed $63M in share repurchases in the quarter; $434M in total executed through April 30, 2024, at an average price of $5.42 per share
$250M
Enact announced an increase to its quarterly dividend, as well as a new share repurchase program with authorization to purchase up to $250 million of common stock
$41M
Continued progress on the long-term care multi-year rate action plan (MYRAP) with $41M of gross incremental premium approvals; $28.3B net present value achieved from in-force rate actions (IFAs) since 2012
314%
U.S. life insurance companies’ RBC1 ratio of 314%2 driven by strong statutory income
$139M
Net income3 of $139M, or $0.31 per diluted share, and adjusted operating income3,4 of $85M, or $0.19 per diluted share
$253M
Genworth holding company cash and liquid assets of $253M at quarter-end
Source: Q1 2024 Earnings Press Release
For complete information regarding our financials, see our periodic filings.
* Non-GAAP financial measure. View full reconciliation in our Q4 earnings press release.
1. Risk-based capital ratio based on company action level for GLIC consolidated.
2. Company estimate for the first quarter of 2024 due to timing of the preparation of the filing(s).
3. All references reflect amounts available to Genworth’s common stockholders.
4. This is a financial measure that is not calculated based on U.S. Generally Accepted Accounting Principles (GAAP). See the Use of Non-GAAP Measures section of this press release for additional information.